Original Research

Published on 14 Sep 2022

A new core–shell-type nanoparticle loaded with paclitaxel/norcantharidin and modified with APRPG enhances anti-tumor effects in hepatocellular carcinoma

in Pharmacology of Anti-Cancer Drugs

Ming-Hua Xie
Zai-Lin Fu
Ai-Lian Hua
Ji-Fang Zhou
Qian Chen
Jian-Bo Li
Shen Yao
Xin-Jun Cai
Min Ge
Li Zhou

Frontiers in Oncology

doi 10.3389/fonc.2022.932156

1,776 views
4 citations

Correction

Published on 13 Sep 2022

Corrigendum: The role of NR4A1 in the pathophysiology of osteosarcoma: A comprehensive bioinformatics analysis of the single-cell RNA sequencing dataset

in Pharmacology of Anti-Cancer Drugs

Weidong Liu
Yuedong Hao
Xiao Tian
Jing Jiang
Quanhe Qiu

Frontiers in Oncology

doi 10.3389/fonc.2022.1027056

1,291 views

Editorial

Published on 13 Sep 2022

Editorial: Anakoinosis for promoting tumor tissue editing: Novel therapeutic opportunities for establishing clinically relevant tumor control by targeting tumor plasticity

in Pharmacology of Anti-Cancer Drugs

Daniel Heudobler
Lina Ghibelli
Albrecht Reichle

Frontiers in Oncology

doi 10.3389/fonc.2022.1005381

701 views
2 citations

Brief Research Report

Published on 12 Sep 2022

Further investigation of blockade effects and binding affinities of selected natural compounds to immune checkpoint PD-1/PD-L1

in Pharmacology of Anti-Cancer Drugs

Huifang Li
Navindra P. Seeram
Chang Liu
Hang Ma

Frontiers in Oncology

doi 10.3389/fonc.2022.995461

2,691 views
5 citations

Mini Review

Published on 12 Sep 2022

Deconvoluting the complexity of autophagy in colorectal cancer: From crucial pathways to targeted therapies

in Pharmacology of Anti-Cancer Drugs

Liming Qiang
Hongpeng Li
Zhaohui Wang
Lin Wan
Guangfu Jiang

Frontiers in Oncology

doi 10.3389/fonc.2022.1007509

1,989 views
3 citations

Review

Published on 12 Sep 2022

Targeted and cellular therapies in lymphoma: Mechanisms of escape and innovative strategies

in Pharmacology of Anti-Cancer Drugs

Anagha Deshpande
Javier Munoz

Frontiers in Oncology

doi 10.3389/fonc.2022.948513

5,037 views
3 citations

Case Report

Published on 12 Sep 2022

Case report: ZEB1 expression in three cases of hepatic carcinosarcoma

in Pharmacology of Anti-Cancer Drugs

Mingming Zhang
Dongchang Yang
Lu Li
Lin Liu
Ting Wang
Tao Liu
Lei Li
Yanrong Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.972650

1,749 views

Review

Published on 08 Sep 2022

The recent advances of cancer associated fibroblasts in cancer progression and therapy

in Pharmacology of Anti-Cancer Drugs

Chenxi Wu
Jianmei Gu
Hongbing Gu
XiaoXin Zhang
Xu Zhang
Runbi Ji

Frontiers in Oncology

doi 10.3389/fonc.2022.1008843

5,027 views
5 citations

Review

Published on 08 Sep 2022

Inhibition and potential treatment of colorectal cancer by natural compounds via various signaling pathways

in Pharmacology of Anti-Cancer Drugs

Mingchuan Wang
Xianjun Liu
Tong Chen
Xianbin Cheng
Huijie Xiao
Xianglong Meng
Yang Jiang

Frontiers in Oncology

doi 10.3389/fonc.2022.956793

5,044 views
10 citations

Review

Published on 05 Sep 2022

Evaluation of the potential of ultrasound-mediated drug delivery for the treatment of ovarian cancer through preclinical studies

in Pharmacology of Anti-Cancer Drugs

Yi-Chao Wang
Jing-Yan Tian
Ying-Ying Han
Yun-Fei Liu
Si-Yao Chen
Feng-Jun Guo

Frontiers in Oncology

doi 10.3389/fonc.2022.978603

2,499 views
3 citations

Mini Review

Published on 05 Sep 2022

Overcoming resistance to PD-1/PD-L1 inhibitors in esophageal cancer

in Pharmacology of Anti-Cancer Drugs

Chao Cheng
Lingdun Zhuge
Xin Xiao
Siyuan Luan
Yong Yuan

Frontiers in Oncology

doi 10.3389/fonc.2022.955163

3,941 views
10 citations

Original Research

Published on 02 Sep 2022

CRISPR/Cas9-3NLS/sgHMGA2@PDA nanosystem is the potential efficient gene editing therapy for gastric cancer with HMGA2 high expression

in Pharmacology of Anti-Cancer Drugs

Zhouying Wu
Xue Huo
Tingyu Yang
Kun Liu
Ting Wu
Zongqi Feng
Min Wang
Feng Li
Jianchao Jia
Xiaoran Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.978533

2,693 views
2 citations

Original Research

Published on 30 Aug 2022

Tumor-infiltrating immune cells based TMEscore and related gene signature is associated with the survival of CRC patients and response to fluoropyrimidine-based chemotherapy

in Pharmacology of Anti-Cancer Drugs

Xian-Wen Guo
Si-Qi Li
Rong-E Lei
Zhen Ding
Bang-li Hu
Rong Lin

Frontiers in Oncology

doi 10.3389/fonc.2022.953321

1,875 views
2 citations

Systematic Review

Published on 29 Aug 2022

Integration of healthy volunteers in early phase clinical trials with immuno-oncological compounds

in Pharmacology of Anti-Cancer Drugs

Igor Radanovic
Naomi Klarenbeek
Robert Rissmann
Geert Jan Groeneveld
Emilie M. J. van Brummelen
Matthijs Moerland
Jacobus J. Bosch

Frontiers in Oncology

doi 10.3389/fonc.2022.954806

5,490 views
1 citation

Original Research

Published on 29 Aug 2022

Effect of glycated hemoglobin A1c on the survival of patients with oral squamous cell carcinoma: A multi-institutional database cohort study

in Pharmacology of Anti-Cancer Drugs

Chun-Yuan Chao
Sheng-Dean Luo
Wei-Chih Chen
Shao-Chun Wu
Tai-Jan Chiu
Yu-Ming Wang
Yao-Hsu Yang
Fu-Min Fang
Shau-Hsuan Li
Chung-Yi Li

Frontiers in Oncology

doi 10.3389/fonc.2022.952616

2,228 views
3 citations

Review

Published on 24 Aug 2022

Clinical applications of circulating tumor cells in hepatocellular carcinoma

in Pharmacology of Anti-Cancer Drugs

Yinggang Hua
Jingqing Dong
Jinsong Hong
Bailin Wang
Yong Yan
Zhiming Li

Frontiers in Oncology

doi 10.3389/fonc.2022.968591

2,791 views
6 citations

Navigation group

Articles

A new core–shell-type nanoparticle loaded with paclitaxel/norcantharidin and modified with APRPG enhances anti-tumor effects in hepatocellular carcinoma

Corrigendum: The role of NR4A1 in the pathophysiology of osteosarcoma: A comprehensive bioinformatics analysis of the single-cell RNA sequencing dataset

Editorial: Anakoinosis for promoting tumor tissue editing: Novel therapeutic opportunities for establishing clinically relevant tumor control by targeting tumor plasticity

Further investigation of blockade effects and binding affinities of selected natural compounds to immune checkpoint PD-1/PD-L1

Deconvoluting the complexity of autophagy in colorectal cancer: From crucial pathways to targeted therapies

Targeted and cellular therapies in lymphoma: Mechanisms of escape and innovative strategies

Case report: ZEB1 expression in three cases of hepatic carcinosarcoma

The recent advances of cancer associated fibroblasts in cancer progression and therapy

Inhibition and potential treatment of colorectal cancer by natural compounds via various signaling pathways

Evaluation of the potential of ultrasound-mediated drug delivery for the treatment of ovarian cancer through preclinical studies

Overcoming resistance to PD-1/PD-L1 inhibitors in esophageal cancer

CRISPR/Cas9-3NLS/sgHMGA2@PDA nanosystem is the potential efficient gene editing therapy for gastric cancer with HMGA2 high expression

Tumor-infiltrating immune cells based TMEscore and related gene signature is associated with the survival of CRC patients and response to fluoropyrimidine-based chemotherapy

Integration of healthy volunteers in early phase clinical trials with immuno-oncological compounds

Effect of glycated hemoglobin A1c on the survival of patients with oral squamous cell carcinoma: A multi-institutional database cohort study

Clinical applications of circulating tumor cells in hepatocellular carcinoma